BioCentury
ARTICLE | Clinical News

ARIES Norovirus Assay from Luminex receives CE-IVD Mark approval

July 21, 2017 1:00 AM UTC

Luminex Corp. (NASDAQ:LMNX) said its ARIES Norovirus Assay received CE-IVD Mark approval in Europe. The real-time, PCR-based qualitative in vitro diagnostic detects and differentiates norovirus genog...

BCIQ Company Profiles

Luminex Corp.